DRUG R&D IN CHINA--Status, Opportunity, International Collaboration and Challenges
Organizer by
Northeastern Section of American Chemical Society (NESACS)
Chinese-American BioMedical Association (CABA)
Saturday, May 22nd, 2010
Holiday Inn (15 Middlesex Canal Park Road, Woburn, MA)
Northeastern Section of American Chemical Society (NESACS) and Chinese -American Biomedical Association (CABA) are organizing a scientific symposium on Saturday, May 22 at Holiday Inn of Woburn, MA (15 Middlesex Canal Park Road). This symposium will feature "Drug R&D in China: Status, Opportunity, International Collaboration and Challenges". Comparing to the well-established Chinese Pharmaceutical CRO services sector, China's innovative drug R&D has shown its momentum only in recent several years. Prominent academic professors and seasoned industrial scientists and executives from both China and US will share their views on China's drug R&D and the impact to the global pharmaceutical industry. Don't miss this unique opportunity to learn about China's drug R&D status and to network with leaders in this field.
To attend the symposium, please pre-register before May 19 by accepting the Evite invitation. Please put down your full name and affiliation so that a proper nametag can be prepared for you by the organizers for the meeting.
Price for the day program is $30 for ACS members, $20 for CABA members, and $35 for non-members. Please pay cash or check on-site.
See www.NESACS.org or www.cabaweb.org for updates. Questions can be directed to Liming.Shao@sepracor.com
Print Invitation
